Human Cytomegalovirus-Induced Inhibition of Cytotrophoblast Invasion

人巨细胞病毒诱导的细胞滋养层侵袭抑制

• 批准号: 7614343
• 负责人: CINDY Anne MORRIS
• 金额: $ 29.97万
• 依托单位: TULANE UNIVERSITY OF LOUISIANA
• 依托单位国家: 美国
• 财政年份: 2008
• 资助国家: 美国
• 起止时间: 2008-04-15 至 2013-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7614343
• 关键词: 3-Dimensional; Affect; Bioreactors; Cell Line; Cells; Communities; Cytomegalovirus; Cytomegalovirus Infections; Data; Embryo; Environment; Event; Exhibits; Experimental Designs; Fetal Growth Retardation; Fetus; Fibrin; First Pregnancy Trimester; Gelatinase A; Gelatinase B; Gene Expression; Glycoproteins; Goals; Growth Factor; Herpesviridae; Human Herpesvirus 4; Hypoxia; Immediate-Early Genes; Immediate-Early Proteins; Infection; Interleukin-10; Interstitial Collagenase; Invaded; Kinetics; Lytic; Maternal-Fetal Exchange; Matrix Metalloproteinase Inhibitor; Matrix Metalloproteinases; Mediating; Metalloproteases; Modeling; Molecular; Morbidity - disease rate; Myometrial; Oxygen; Partial Pressure; Pathology; Phenotype; Placenta; Placentation; Plasminogen Activator Inhibitor 1; Pre-Eclampsia; Pregnancy; Pregnancy loss; Pregnant Uterus; Premature Birth; Premature Labor; Proteins; Research Personnel; Side; Signal Transduction; Site; Spiral Artery of the Endometrium; Staging; Stromelysin 1; System; Technology; Testing; Tissue Engineering; Tissues; Transforming Growth Factors; Up-Regulation; Viral; Viral Genes; Viral Proteins; Virion; Woman; congenital infection; cytokine; cytotrophoblast; fetal; implantation; in vitro Model; in vivo Model; inhibitor/antagonist; interstitial; lytic replication; migration; mortality; novel; planetary Atmosphere; protein expression; public health relevance; reactivation from latency; reproductive; therapeutic target; trophoblast

DESCRIPTION (provided by applicant): Significant morbidity and mortality is associated with symptomatic congenital infection with the herpes virus human cytomegalovirus (HCMV). Fifteen percent of women with primary HCMV infection spontaneously abort during early pregnancy; and it is the placenta, not the embryo or fetus that shows evidence of infection. Pathological consequences of placental HCMV infection, including first trimester pregnancy loss, intrauterine growth restriction, pre-eclampsia and preterm labor, are believed to be mediated by the inability of extravillous cytotrophoblasts (EVT) to adequately invade the uterine wall during early first trimester pregnancy resulting in impaired remodeling of maternal spiral arteries and shallow placentation. Preliminary studies demonstrate that HCMV infection of first trimester EVT results in inhibition of EVT invasion and in significant reduction of expression and activity of invasion-promoting matrix metalloproteinase (MMP)-2 and MMP-9. HCMV-induced inhibition of EVT occurs along with increased expression of transforming growth factor (TGF)-21, a factor known to inhibit EVT invasion. Since EVT invasion occurs during first trimester pregnancy when the fetal side of the placental environment is relatively hypoxic and since hypoxia, in other systems, is capable of activating herpesvirus gene expression and lytic replication, low oxygen partial pressure during placentation may actually augment the ability of HCMV to inhibit EVT invasion. To determine the molecular mechanism(s) by which HCMV inhibits EVT invasion, which is the broad, long-term objective of the studies proposed herein, a novel, biologically relevant model of EVT invasion has been developed using bioreactor tissue engineering technology. The hypotheses of the studies proposed are that that HCMV, and more specifically, the viral envelope glycoprotein B (gB) and/or immediate- early gene products, IE1-72 and IE2-86, inhibit EVT invasion during placentation through activation of TGF-21 and modulation of MMP activity; and further, that hypoxia increases the ability of HCMV to inhibit EVT invasion through upregulation of HCMV IE expression and lytic replication. The Specific Aims to test these hypotheses are (1) to determine whether the inhibition of invasion of cultured EVT by HCMV is mediated by early events in the HCMV replication cycle (2) to determine whether HCMV represses invasion- promoting MMP-2, MMP-3, MMP-9 and uPA, and upregulates invasion-repressing TIMP-1, TIMP-2 and PAI-1 in cultured EVT and whether HCMV inhibits the invasiveness of cultured EVT through activation of TGF-21 and (3) to determine whether the relatively hypoxic atmosphere encountered by differentiating CTB during first trimester pregnancy enhances HCMV-induced inhibition of interstitial and endovascular invasion by EVT through increased lytic HCMV replication. Elucidating mechanisms by which HCMV impairs placentation may be key to understanding fetal and maternal pathologies associated with intrauterine HCMV infection. PUBLIC HEALTH RELEVANCE: Fifteen percent of women with primary human cytomegalovirus (HCMV) infection spontaneously abort during early pregnancy, and it is the placenta, not the embryo or fetus, that shows evidence of infection. Additionally, HCMV infection may cause premature delivery, intrauterine growth restriction or pre-eclampsia, all of which are associated with placental pathology. These complications are believed to be, at least in part, the result of inadequate extravillous cytotrophoblast invasion (EVT) of the uterine wall and impaired remodeling of the maternal spiral arteries during early stages of placental development. Defining how HCMV impairs EVT invasion is of major importance to the reproductive community and may provide additional therapeutic targets to maintain viable pregnancy.

描述(由申请人提供)：明显的发病率和死亡率与有症状的先天性人类巨细胞病毒(HCMV)感染有关。15%的患有原发巨细胞病毒感染的妇女在怀孕早期自发流产；显示感染证据的是胎盘，而不是胚胎或胎儿。胎盘HCMV感染的病理后果，包括妊娠早期丢失、宫内生长受限、先兆子痫和早产，被认为是由于绒毛外细胞滋养细胞(EVT)在妊娠早期不能充分侵入子宫壁，导致母亲螺旋动脉重塑受损和胎盘浅。初步研究表明，妊娠早期人巨细胞病毒感染可抑制EVT的侵袭，促进侵袭的基质金属蛋白酶(MMP2)和MMP9的表达和活性显著降低。HCMV诱导的EVT抑制伴随着转化生长因子(TGF)-21表达的增加，这是一种已知的抑制EVT侵袭的因子。由于EVT的侵袭发生在妊娠早期，此时胎盘环境的胎儿侧相对低氧，而且由于在其他系统中，低氧能够激活疱疹病毒基因的表达和裂解复制，因此胎盘形成期间的低氧分压实际上可能增强HCMV抑制EVT侵袭的能力。为了确定巨细胞病毒抑制EVT侵袭的分子机制(S)，这是本文提出的广泛的长期目标，我们利用生物反应器组织工程技术建立了一种新的生物学相关的EVT侵袭模型。这些研究提出的假设是，HCMV，更具体地说，是病毒包膜糖蛋白B(GB)和/或即刻早期基因产物IE1-72和IE2-86，通过激活转化生长因子-21和调节基质金属蛋白酶活性来抑制胎盘形成过程中的EVT侵袭；此外，低氧通过上调HCMV IE的表达和裂解复制来增强HCMV抑制EVT侵袭的能力。这些假设的具体目的是：(1)确定HCMV对体外培养的EVT侵袭的抑制是否通过HCMV复制周期中的早期事件介导；(2)确定HCMV是否抑制体外培养的EVT侵袭促进基质金属蛋白酶-2、基质金属蛋白酶-3、基质金属蛋白酶-9和uPA的侵袭，上调侵袭抑制TIMP-1、TIMP-2和PAI-1，以及HCMV是否通过激活转化生长因子-21抑制培养的EVT的侵袭；以及(3)确定妊娠早期通过分化CTB所遇到的相对低氧环境是否增强了HCMV诱导的EVT对HCMV复制的间质和血管内膜侵袭的抑制作用。阐明HCMV损害胎盘形成的机制可能是了解与宫内HCMV感染相关的胎儿和母体病理的关键。公共卫生相关性：15%感染了人类巨细胞病毒(HCMV)的妇女在怀孕早期自发流产，表明感染的证据是胎盘，而不是胚胎或胎儿。此外，人巨细胞病毒感染可能导致早产、宫内生长受限或先兆子痫，所有这些都与胎盘病理有关。这些并发症被认为至少部分是由于胎盘发育早期绒毛外细胞滋养细胞侵袭(EVT)不足和母体螺旋动脉重塑受损所致。明确HCMV如何损害EVT的侵袭对生殖界具有重要意义，并可能为维持可存活妊娠提供额外的治疗靶点。